Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et al
- PMID: 34656974
- DOI: 10.1136/heartjnl-2021-320124
Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Joshi et al
Keywords: cardiomyopathy; coronary artery disease; dilated; metabolic diseases.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Yalta et al.Heart. 2021 Dec;107(23):1922-1923. doi: 10.1136/heartjnl-2021-320174. Epub 2021 Oct 16. Heart. 2021. PMID: 34656972 No abstract available.
Comment on
-
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.Heart. 2021 Jun 11;107(13):1032-1038. doi: 10.1136/heartjnl-2020-318060. Heart. 2021. PMID: 33637556 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical